Homosalate has not been proven harmful during pregnancy, but it raises enough safety questions that most dermatology guidance steers pregnant women toward mineral sunscreens instead. The FDA has not classified homosalate as “generally recognized as safe and effective,” and Europe’s Scientific Committee on Consumer Safety recently slashed its recommended safe concentration from 10% down to just 0.5% in finished products. Here’s what the evidence actually shows.
What Homosalate Does in the Body
Homosalate is a chemical UV filter that absorbs UVB rays to prevent sunburn. Unlike mineral filters that sit on top of the skin, chemical filters like homosalate are designed to be absorbed into the upper layers of skin, where they convert UV radiation into heat. The problem is that absorption doesn’t always stop at the skin. Chemical sunscreen ingredients, including homosalate, can enter the bloodstream after topical application, and the FDA has flagged that more data is needed before it can confirm these ingredients are safe and effective.
For context, the only two sunscreen active ingredients the FDA currently classifies as GRASE are zinc oxide and titanium dioxide, both mineral filters. Homosalate, along with oxybenzone, avobenzone, octinoxate, and several others, sits in a regulatory gray zone where the agency has explicitly requested additional safety data.
Hormonal Activity Concerns
The biggest red flag for pregnancy comes from homosalate’s ability to interfere with hormones. Lab studies using human cells and animal models have found that homosalate has estrogenic effects (it mimics estrogen) and anti-androgenic effects (it blocks the action of testosterone). In zebrafish studies, exposure to homosalate significantly decreased testosterone levels, increased estradiol (the main form of estrogen), and disrupted the activity of genes involved in hormone production. These effects were traced to the steroidogenic pathway, meaning homosalate appears to alter the way the body manufactures sex hormones rather than simply binding to hormone receptors.
During pregnancy, the balance of estrogen, progesterone, and androgens plays a critical role in fetal development, placental function, and the timing of delivery. Any compound that shifts those hormone levels is worth scrutinizing carefully, even if the concentrations reaching the bloodstream from a single sunscreen application are low.
Does Homosalate Reach the Fetus?
Research on placental transfer is limited but somewhat reassuring on one front. A Swiss study looking at human placental tissue did not detect homosalate, suggesting it may not cross the placenta in significant amounts. However, the compound has been detected in human breast milk. A large Chinese study measuring UV filter concentrations in 100 pooled breast milk samples from 24 provinces found homosalate at a mean concentration of 27 nanograms per gram of milk fat, making it the second most abundant UV filter detected (about 12% of the total UV filter load in breast milk).
This means that even if placental transfer appears minimal, the compound does accumulate in the body enough to show up in breast milk. For pregnant women, the practical takeaway is that homosalate is being absorbed systemically, even if it may not be reaching the fetus directly through the placenta.
Europe’s Dramatic Safety Revision
Perhaps the most telling signal comes from European regulators. The EU’s Scientific Committee on Consumer Safety reviewed the available evidence on homosalate and concluded that its use as a UV filter in cosmetics is safe only up to a maximum concentration of 0.5%. This is a dramatic reduction. Many sunscreens on the market contain homosalate at concentrations of 10% to 15%. A limit of 0.5% essentially means that, at the levels commonly found in commercial sunscreens, the committee does not consider homosalate safe for general consumers, let alone pregnant women.
The U.S. has not adopted a similar restriction. American sunscreens can still contain homosalate at much higher concentrations, which creates a gap between what’s available on store shelves and what the latest safety science supports.
Safer Sunscreen Options During Pregnancy
Sun protection during pregnancy is important. Pregnancy hormones make skin more susceptible to hyperpigmentation (melasma), and UV exposure worsens it. Skipping sunscreen altogether isn’t the answer. The goal is choosing a formulation with a stronger safety profile.
Mineral sunscreens containing zinc oxide and titanium dioxide are widely recommended as the first choice for pregnant and breastfeeding women. These filters work by sitting on the skin’s surface and physically reflecting UV rays rather than being absorbed into the body. They provide broad-spectrum protection against both UVA and UVB, have minimal systemic absorption, and carry a low risk of endocrine disruption or bioaccumulation. They’re the only sunscreen ingredients the FDA currently classifies as GRASE.
The tradeoff is cosmetic. Mineral sunscreens can leave a white cast, feel thicker on the skin, and be harder to blend, especially on darker skin tones. Newer micronized and tinted formulations have improved this significantly. If cosmetic feel is keeping you from using sunscreen consistently, a tinted mineral sunscreen or one marketed as “sheer” can help with adherence, which matters more than the perfect formulation sitting unused in a drawer.
How to Check Your Sunscreen
Homosalate will be listed as an active ingredient on the product label, typically near the top of the Drug Facts panel on any sunscreen sold in the U.S. It often appears alongside other chemical filters like avobenzone, octisalate, and octocrylene. If your current sunscreen contains homosalate and you’re pregnant or planning to become pregnant, switching to a mineral-only formula is straightforward. Look for products where the only active ingredients listed are zinc oxide, titanium dioxide, or both.
Keep in mind that some sunscreens labeled “mineral” still include chemical filters in the mix. Always check the active ingredients rather than relying on front-of-package marketing claims.